tiprankstipranks
Novo Nordisk (DE:NOV)
XETRA:NOV

Novo Nordisk (NOV) Technical Analysis

126 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Novo Nordisk’s (NOV) Moving Averages Convergence Divergence (MACD) indicator is -1.75, suggesting Novo Nordisk is a Buy.
Novo Nordisk’s (NOV) 20-Day exponential moving average is 128.12, while Novo Nordisk’s (NOV) share price is €121.13, making it a Sell.
Novo Nordisk’s (NOV) 50-Day exponential moving average is 127.21, while Novo Nordisk’s (NOV) share price is €121.13, making it a Sell.

Novo Nordisk (NOV) Pivot Points

Jul 23, 2024, 08:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
107.19
112.09
114.55
119.45
121.91
126.81
129.27
Fibonacci
112.09
114.90
116.64
119.45
122.26
124.00
126.81
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Novo Nordisk (NOV) Moving Averages

Jul 23, 2024, 08:52 PM
Period
Simple
Exponential
MA5
124.36Sell
123.30Sell
MA10
127.31Sell
125.99Sell
MA20
130.19Sell
128.12Sell
MA50
128.38Sell
127.21Sell
MA100
123.05Sell
122.02Sell
MA200
109.78Buy
110.43Buy
Novo Nordisk’s (NOV) 10-Day exponential moving average is 125.99, while Novo Nordisk’s (NOV) share price is €121.13, making it a Sell.
Novo Nordisk’s (NOV) 100-Day exponential moving average is 122.02, while Novo Nordisk’s (NOV) share price is €121.13, making it a Sell.
Novo Nordisk’s (NOV) stock price is €121.13 and Novo Nordisk’s (NOV) 50-day simple moving average is 128.38, creating a Sell signal.
Novo Nordisk’s (NOV) stock price is €121.13 and Novo Nordisk’s (NOV) 100-day simple moving average is 123.05, creating a Sell signal.
Novo Nordisk’s (NOV) stock price is €121.13 and Novo Nordisk’s (NOV) 200-day simple moving average is 109.78, creating a Buy signal.

Novo Nordisk (NOV) Technical Indicators

Jul 23, 2024, 08:52 PM
Name
Value
Implied Action
RSI (14)
38.88
Neutral
STOCH (9,6)
12.16
Buy
STOCHRSI (14)
9.82
Buy
MACD (12,26)
-1.75
Buy
ADX (14)
24.98
Neutral
Williams %R
-76.81
Buy
CCI (14)
-198.43
Buy
ATR (14)
3.62
-
Ultimate Oscillator
31.55
Neutral
ROC
-10.51
Sell
Novo Nordisk’s (NOV) Relative Strength Index (RSI) is 38.88, creating a Neutral signal.
Novo Nordisk’s (NOV) Trend Strength Indicator (ADX) is 24.98, creating a Neutral signal.
Novo Nordisk’s (NOV) Commodity Channel Index (CCI) is -198.43, creating a Buy signal.
Novo Nordisk’s (NOV) Price Rate of Change (ROC) is -10.51, creating a Sell signal.

FAQ

Is NOV a Buy, Hold, or Sell?
Based on NOV’s technical indicators, NOV is a Sell.
    What is NOV’s RSI (14)?
    NOV’s RSI (14) is 38.88, which suggests NOV is a Neutral.
      What is NOV’s MACD?
      NOV’s MACD is -1.75, which suggests NOV is a Buy.
        What is NOV’s 5-day moving average?
        NOV’s 5-day moving average is 124.36, which suggests NOV is a Sell.
          What is NOV’s 20-day moving average?
          NOV 20-day moving average is 130.19, which suggests NOV is a Sell.
            What is NOV’s 50-day moving average?
            NOV’s 50-day moving average is 128.38, which suggests NOV is a Sell.
              What is NOV’s 200-day moving average?
              NOV’s 200-day moving average is 109.78, which suggests NOV is a Buy.
                What is NOV’s Williams % R (14)?
                NOV’s Williams % R (14) is -76.81, which suggests NOV is a Buy.
                  What is NOV’s CCI (14)?
                  NOV’s CCI (14) is -198.43, which suggests NOV is a Buy.
                    What is the share price of Novo Nordisk?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis